98%
921
2 minutes
20
The primary aim of our study was to investigate the genetic correlations, colocalized genes, and causal relationships between craniofacial microsomia (CFM) and 33 diseases (including tumours and respiratory, heart, and kidney diseases). On the basis of extensive summary-level data from genome-wide association studies (GWASs), we evaluated the genetic linkage between CFM and a spectrum of 33 medical conditions using linkage disequilibrium score regression (LDSC). We employed PLACO to identify pleiotropic loci and genes associated with CFM and other diseases. These genes were subsequently subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Finally, the causal effect of CFM on the 33 diseases was assessed through Mendelian randomization (MR). We observed a genetic association between CFM and malignant lymphoma, thyroid cancer, and chronic obstructive pulmonary disease. The PLACO analysis identified 172 potential multi-effect loci (P < 5 × 10- 8). Furthermore, the MAGMA analysis of colocalized single nucleotide polymorphisms (SNPs) revealed that 1,760 SNPs shared genes (P < 0.05/18,345 = 2.726e-6). KEGG analysis revealed enrichment of these genes in the calcium signalling pathway. Finally, Mendelian randomization (MR) analysis suggested that CFM may reduce the risk of developing urolithiasis (IVW: OR = 0.989, 95% CI = 0.979-0.999, p = 0.034). Our study reveals for the first time the genetic associations of CFM with three diseases (malignant lymphoma, thyroid cancer and chronic obstructive pulmonary disease) in an Asian population. In addition, we found a common calcium signalling pathway between these three diseases and CFM. These results provide new insights into the pathogenesis and research potential of CFM.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12325793 | PMC |
http://dx.doi.org/10.1038/s41598-025-04557-5 | DOI Listing |
Mol Ther Methods Clin Dev
June 2025
Université Paris-Saclay, University Evry, Inserm, Genethon, Integrare Research Unit UMR_S951, 91000 Evry, France.
Pompe disease is a glycogen storage disorder caused by mutations in the acid α-glucosidase (GAA) gene, leading to reduced GAA activity and glycogen accumulation in heart and skeletal muscles. Enzyme replacement therapy with recombinant GAA, the standard of care for Pompe disease, is limited by poor skeletal muscle distribution and immune responses after repeated administrations. The expression of GAA in muscle with adeno-associated virus (AAV) vectors has shown limitations, mainly the low targeting efficiency and immune responses to the transgene.
View Article and Find Full Text PDFJ Neurol Surg B Skull Base
October 2025
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States.
Objectives: Patients undergoing surgery for Cushing's disease may be more likely to be readmitted to the hospital than other patients with pituitary disorders. We investigated rates, causes, and predictors of unplanned readmission following transsphenoidal surgery for Cushing's disease to identify areas for clinical, financial, and administrative improvements.
Design: Retrospective cohort study.
Transl Oncol
August 2025
Department of Protein Science, AlbaNova University Center, KTH Royal Institute of Technology, SE-144 21 Stockholm, Sweden; Science for Life Laboratories, Karolinska Institute, SE-171 65 Solna, Sweden. Electronic address:
We report development and characterization of small non-immunoglobulin affibody affinity proteins directed to the highly glycosylated human carcinoembryonic antigen-related adhesion molecule 5 (CEACAM5, CEA), and their use in immunohistochemical (IHC) analyses of human pancreatic cancer samples and for in vivo tumor imaging. A total of nineteen unique anti-CEA affibodies were identified from large phage display libraries constructed using combinatorial protein engineering of a small 58 amino acid three-helix bundle protein domain. Molecular modeling suggested that all enriched clones share a binding surface with several clustered tryptophan residues interacting with a hydrophobic patch in the N1 domain of CEA centered around a phenylalanine residue.
View Article and Find Full Text PDFLiver Int
September 2025
Gilead Sciences, Foster City, California, USA.
Background & Aims: This US-based study assessed the impact of pruritus on health-related quality of life (HRQoL) and treatment experiences of people with primary biliary cholangitis (PBC).
Methods: Patients with PBC were recruited from a physician panel and patient advocacy group. Participants were grouped by the Pruritus Numerical Rating Scale (NRS): No/Mild Pruritus (NMP, NRS < 4) and Moderate/Severe Pruritus (MSP, NRS ≥ 4).
J Colloid Interface Sci
August 2025
Biochemistry and Molecular Biology Department, Faculty of Biological Sciences, Complutense University, Madrid, Spain; Research Institute "Hospital Universitario 12 de Octubre (imas12)", Complutense University, Madrid, Spain. Electronic address:
Deciphering the molecular structure of pulmonary surfactant (PS) at the respiratory air-liquid interface has remained a major challenge since its discovery. This is particularly critical at minimal lung volume and surface area at the end of exhalation, when PS rapidly reorganizes into a 3D membrane network without detaching from the interfacial film, ensuring readiness and stability for subsequent respiratory cycles. Using neutron reflectometry and epifluorescence microscopy in specially designed surface balances, we have investigated the structure of model PS membranes and films at different compression stages, focusing on the key roles of the hydrophobic surfactant proteins SP-B and SP-C in the organization of the system at the interface.
View Article and Find Full Text PDF